Weight-Loss drug tested for common hormone disorder
NCT ID NCT06222437
Summary
This study planned to test whether semaglutide, a medication often used for weight loss and diabetes, could help women with Polycystic Ovary Syndrome (PCOS). Researchers wanted to see if it improved ovulation, menstrual regularity, hormone levels, and weight. The trial was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYCYSTIC OVARY SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Research Institute at Methodist Health System
Dallas, Texas, 75203, United States
Conditions
Explore the condition pages connected to this study.